Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 
.
.
.
.
     
     

    Featured Stories

    Celebrating One Year in the U.S.

    Visit Toujeo.com for more information.

    Sanofi Stories: The Harmony of Music and Dynamic Change

    For this edition of Sanofi Stories, we spoke with Heather Lee Whipple, Senior Director, US Market Access at Sanofi US about navigating dynamic change in healthcare. Check it out to learn more.

    Sanofi US Issues Voluntary Nationwide Recall of All Auvi-Q® Due to Potential Inaccurate Dosage Delivery

    Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q® currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers.

    Social News

    Sanofi’s Commitment to Responsible Data Sharing

    Contact us

    Sanofi US

    55 Corporate Drive
    Bridgewater, NJ 08807

    Follow Us

    Last update: April 15, 2016

     

    Content :